THOMAS RUSSELL BECK, M.D.
Osteopathic Medicine in West Concord, MA
License number
Massachusetts 72340
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
345 Silyen Hill Rd., West Concord, MA 01742
Phone
(978) 369-8445
Professional information
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2008022, Sep 11, 2008
Filed:
Oct 31, 2007
Appl. No.:
11/932098
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/16, A61P 7/00
US Classification:
514 12
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2009022, Sep 10, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/931810
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/16, A61P 9/10, A61P 7/00
US Classification:
514 12
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2009023, Sep 17, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/932184
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/17
US Classification:
514 12
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2013001, Jan 10, 2013
Filed:
Apr 27, 2012
Appl. No.:
13/458086
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert Charles Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert Charles Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Burlington MA
International Classification:
A61K 38/17, A61P 29/00, A61P 9/10, A61K 38/11
US Classification:
514 109, 514 135, 514 122
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
8188045, May 29, 2012
Filed:
May 18, 2007
Appl. No.:
11/804388
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
Dyax Corp. - Burlington MA
International Classification:
A61K 38/16, A61P 7/02, C07K 14/00
US Classification:
514 135, 514 56, 530324
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e. g. , an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e. g. , ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e. g. , reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e. g. , in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2009023, Sep 17, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/932015
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 31/197
US Classification:
514561
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2008018, Aug 7, 2008
Filed:
Oct 31, 2007
Appl. No.:
11/931496
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/16, A61K 38/02, A61P 9/10
US Classification:
514 12, 514 2
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2009022, Sep 10, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/931361
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/16
US Classification:
514 12
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Kallikrein Inhibitors And Anti-Thrombolytic Agents And Uses Thereof
US Patent:
2009024, Oct 1, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/931941
Inventors:
Henry Blair - Boston MA, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Thomas Beck - Concord MA, US
Robert C. Ladner - Ijamsville MD, US
Assignee:
DYAX CORP. - Cambridge MA
International Classification:
A61K 38/12, A61P 7/02
US Classification:
514 11
Abstract:
Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass.
Dr. Thomas Russell Beck - MD (Doctor of Medicine)
Hospitals:
269 Ministerial Dr, Concord 01742
269 Ministerial Dr, Concord 01742
269 Ministerial Dr, Concord 01742
Education:
Medical Schools
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1975
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1975